Table 3.   Median Preclinical and Synthesis-to-Approval Times (mos.) for Psychotropic and

                  All New Chemical Entities Approved in the United States, 1963-1997

The preclinical phase is the time from first pharmacologic testing to first administration in humans

anywhere.  The synthesis-to-approval phase is the time from synthesis of the compound to U.S.

marketing approval.